Briefly, Runx2 neutralizes the pro-apoptotic effect of Myc overexpression and confers a potent survival advantage to thymic lymphomas in Runx2/Myc-ERTM mice (CD2-Runx2 mice crossed with CD2-Myc-ERTM mice). Here, MYC is linked to thymus lymphoma.